Company / Return on Equity (ROE)
IMMUCELL CORP /DE/ Return on Equity (ROE) History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-7.8%
FY2025
5-year range
-23.1% / 11.4%
FY2021-FY2025
Trend
+66.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
IMMUCELL CORP /DE/ reports negative total equity of -7.8% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-7.8% in FY2025 with a 10-year CAGR of -9.1%.
Improved from -8.2% to -7.8% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -9.1pp
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 66.1% year-over-year.
- Peak return on equity (roe) was recorded in FY2016.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -7.8% | +66.1% |
| FY2024 | -23.1% | -181.4% |
| FY2023 | -8.2% | -418.2% |
| FY2017 | 2.6% | -77.4% |
| FY2016 | 11.4% | +800.0% |
| FY2015 | 1.3% | +30.9% |
| FY2014 | 1.0% | +121.4% |
| FY2013 | -4.5% | -9.7% |
| FY2012 | -4.1% | -84.0% |
| FY2011 | -2.3% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026